SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 328 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.82 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $28,761,991 | +16.1% | 237,271 | +9.7% | 0.01% | +25.0% |
| Q2 2023 | $24,775,257 | -7.5% | 216,340 | +11.3% | 0.01% | -20.0% |
| Q1 2023 | $26,797,184 | +26.7% | 194,422 | +19.1% | 0.01% | +25.0% |
| Q4 2022 | $21,157,823 | +89.8% | 163,280 | +61.9% | 0.01% | +100.0% |
| Q3 2022 | $11,147,000 | +26.5% | 100,838 | -14.2% | 0.00% | 0.0% |
| Q2 2022 | $8,811,000 | -26.2% | 117,538 | -23.1% | 0.00% | 0.0% |
| Q1 2022 | $11,943,000 | +111.8% | 152,873 | +144.0% | 0.00% | +100.0% |
| Q4 2021 | $5,640,000 | +30.5% | 62,644 | +34.1% | 0.00% | +100.0% |
| Q3 2021 | $4,322,000 | +63.8% | 46,731 | +37.7% | 0.00% | 0.0% |
| Q2 2021 | $2,638,000 | -59.4% | 33,935 | -61.1% | 0.00% | -50.0% |
| Q1 2021 | $6,499,000 | -46.9% | 87,200 | +21.5% | 0.00% | -50.0% |
| Q4 2020 | $12,232,000 | +30.3% | 71,750 | +7.3% | 0.00% | 0.0% |
| Q3 2020 | $9,388,000 | -23.9% | 66,855 | -13.1% | 0.00% | -20.0% |
| Q2 2020 | $12,340,000 | +50.8% | 76,965 | -8.0% | 0.01% | +25.0% |
| Q1 2020 | $8,184,000 | -27.1% | 83,664 | -3.8% | 0.00% | 0.0% |
| Q4 2019 | $11,223,000 | -27.4% | 86,979 | -57.6% | 0.00% | -33.3% |
| Q3 2019 | $15,458,000 | -7.0% | 205,231 | +87.7% | 0.01% | 0.0% |
| Q2 2019 | $16,617,000 | +73.4% | 109,361 | +36.0% | 0.01% | +50.0% |
| Q1 2019 | $9,583,000 | +3.5% | 80,403 | -5.3% | 0.00% | 0.0% |
| Q4 2018 | $9,262,000 | -7.4% | 84,875 | +37.0% | 0.00% | 0.0% |
| Q3 2018 | $10,005,000 | -16.7% | 61,946 | -31.8% | 0.00% | -20.0% |
| Q2 2018 | $12,004,000 | +50.1% | 90,816 | -15.9% | 0.01% | +66.7% |
| Q1 2018 | $7,999,000 | +56.6% | 107,964 | +17.6% | 0.00% | +50.0% |
| Q4 2017 | $5,109,000 | -24.0% | 91,814 | -38.1% | 0.00% | -33.3% |
| Q3 2017 | $6,723,000 | -35.4% | 148,214 | -52.0% | 0.00% | -50.0% |
| Q2 2017 | $10,410,000 | +270.7% | 308,797 | +225.6% | 0.01% | +500.0% |
| Q1 2017 | $2,808,000 | -46.5% | 94,844 | -50.5% | 0.00% | -66.7% |
| Q4 2016 | $5,253,000 | -81.6% | 191,473 | -58.8% | 0.00% | -82.4% |
| Q3 2016 | $28,565,000 | +61.8% | 465,140 | -49.7% | 0.02% | +54.5% |
| Q2 2016 | $17,652,000 | +813.2% | 925,587 | +834.9% | 0.01% | +1000.0% |
| Q1 2016 | $1,933,000 | -76.5% | 99,006 | -53.5% | 0.00% | -83.3% |
| Q4 2015 | $8,211,000 | +120.5% | 212,825 | +83.5% | 0.01% | +100.0% |
| Q3 2015 | $3,723,000 | -18.9% | 115,954 | -23.1% | 0.00% | -25.0% |
| Q2 2015 | $4,588,000 | +216.4% | 150,778 | +38.1% | 0.00% | +300.0% |
| Q1 2015 | $1,450,000 | -38.8% | 109,213 | -33.3% | 0.00% | -50.0% |
| Q4 2014 | $2,368,000 | – | 163,717 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonic Fund II, L.P. | 112,689 | $14,541,000 | 14.93% |
| Casdin Capital, LLC | 670,000 | $86,457,000 | 7.95% |
| Logos Global Management LP | 226,002 | $29,163,000 | 7.19% |
| Avoro Capital Advisors LLC | 1,760,000 | $227,110,000 | 6.67% |
| Camber Capital Management LP | 600,000 | $77,424,000 | 3.94% |
| STANSBERRY ASSET MANAGEMENT, LLC | 71,133 | $9,179,000 | 3.74% |
| Eventide Asset Management | 996,000 | $128,524,000 | 3.62% |
| CADIAN CAPITAL MANAGEMENT, LP | 550,000 | $70,972,000 | 3.14% |
| RTW INVESTMENTS, LP | 605,762 | $78,168,000 | 2.95% |
| Consonance Capital Management LP | 356,145 | $45,957,000 | 2.80% |